Jazz Pharmaceuticals Plc
(NASDAQ : JAZZ)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MDCOThe Medicines Co.
-0.05%84.0320.1%$614.99m
AMRNAmarin Corp. Plc
0.13%22.841.7%$318.94m
VRXValeant Pharmaceuticals International, Inc.
6.63%31.2814.1%$184.06m
ARQLArQule, Inc.
-0.97%20.010.6%$136.94m
SAGESAGE Therapeutics, Inc.
2.94%70.698.6%$121.05m
BHCBausch Health Cos., Inc.
6.67%31.290.0%$115.64m
ICPTIntercept Pharmaceuticals, Inc.
-3.23%115.5116.9%$91.79m
JAZZJazz Pharmaceuticals Plc
0.65%149.092.3%$91.14m
GWPHGW Pharmaceuticals Plc
2.99%105.966.2%$85.08m
PRGOPerrigo Co. Plc
0.95%54.326.8%$65.40m
AXSMAxsome Therapeutics, Inc.
2.31%49.182.0%$60.85m
HZNPHorizon Therapeutics Plc
2.36%33.016.6%$43.86m
ICLRICON plc
-0.17%161.464.2%$43.09m
UTHRUnited Therapeutics Corp.
0.34%92.8014.3%$35.89m
ENDPEndo International Plc
7.06%4.708.8%$33.53m

Company Profile

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Dublin, Ireland.